Matches in SemOpenAlex for { <https://semopenalex.org/work/W2079384850> ?p ?o ?g. }
Showing items 1 to 74 of
74
with 100 items per page.
- W2079384850 abstract "Felodipine is a new dihydropyridine calcium antagonist, and in hypertension it is a much more effective third-line drug than hydralazine. Nifedipine, on the other hand, is the established dihydropyridine calcium antagonist that has been increasingly used to treat hypertension. Information is now needed on the relative merits and demerits of these two drugs. This study appraised, there fore, the therapeutic utility of twelve months' treatment with nifedipine 20-60 mg twice daily in 55 patients with previous drug-resistant hypertension who had been successfully treated for the previous year with felodipine 5-20 mg twice daily, each calcium antagonist being used in combination with atenolol 100 mg daily with or without chlorthalidone 25 mg daily. Initially, nifedipine main tained comparable blood pressure control to that which had been achieved by felodipine, although in the longer term (over eight months) nifedipine proved less effective than felodipine had (p < 0.02) and more patients became uncon trolled (supine diastolic blood pressure, Phase V, ≥90 mmHg) on the maximum tolerated dose of the calcium antagonist (χ 2 =4.13, p < 0.05 > 0.025). The former degree of blood pressure control was, however, reestablished by increas ing the dose of nifedipine or reintroducing the diuretic as necessary, and this control was maintained over the next four months. Minor side efects were less common on nifedipine than they had been during the preceding felodipine treatment phase. Felodipine thus has more pronounced and sustained antihypertensive effects than nifedipine, though its side effect burden may appear to be greater. Because of possible treatment order effects and the development of tolerance to dihydro pyridine side effects, formal comparison of these two compounds is warranted." @default.
- W2079384850 created "2016-06-24" @default.
- W2079384850 creator A5036627481 @default.
- W2079384850 creator A5073726169 @default.
- W2079384850 creator A5087819657 @default.
- W2079384850 date "1986-11-01" @default.
- W2079384850 modified "2023-09-27" @default.
- W2079384850 title "Felodipine Compared to Nifedipine as Third-Line Drug in Resistant Hypertension" @default.
- W2079384850 cites W1989591143 @default.
- W2079384850 cites W1990637744 @default.
- W2079384850 cites W1998146750 @default.
- W2079384850 cites W2045366964 @default.
- W2079384850 cites W2056422691 @default.
- W2079384850 cites W2058161414 @default.
- W2079384850 cites W2076646096 @default.
- W2079384850 cites W2100104377 @default.
- W2079384850 cites W2108404098 @default.
- W2079384850 cites W2145407532 @default.
- W2079384850 doi "https://doi.org/10.1177/000331978603701108" @default.
- W2079384850 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/3789464" @default.
- W2079384850 hasPublicationYear "1986" @default.
- W2079384850 type Work @default.
- W2079384850 sameAs 2079384850 @default.
- W2079384850 citedByCount "7" @default.
- W2079384850 crossrefType "journal-article" @default.
- W2079384850 hasAuthorship W2079384850A5036627481 @default.
- W2079384850 hasAuthorship W2079384850A5073726169 @default.
- W2079384850 hasAuthorship W2079384850A5087819657 @default.
- W2079384850 hasConcept C126322002 @default.
- W2079384850 hasConcept C170493617 @default.
- W2079384850 hasConcept C2776525901 @default.
- W2079384850 hasConcept C2776885963 @default.
- W2079384850 hasConcept C2779066535 @default.
- W2079384850 hasConcept C2780361556 @default.
- W2079384850 hasConcept C2780427769 @default.
- W2079384850 hasConcept C2780648877 @default.
- W2079384850 hasConcept C2781212610 @default.
- W2079384850 hasConcept C42219234 @default.
- W2079384850 hasConcept C519063684 @default.
- W2079384850 hasConcept C71924100 @default.
- W2079384850 hasConcept C84393581 @default.
- W2079384850 hasConcept C98274493 @default.
- W2079384850 hasConceptScore W2079384850C126322002 @default.
- W2079384850 hasConceptScore W2079384850C170493617 @default.
- W2079384850 hasConceptScore W2079384850C2776525901 @default.
- W2079384850 hasConceptScore W2079384850C2776885963 @default.
- W2079384850 hasConceptScore W2079384850C2779066535 @default.
- W2079384850 hasConceptScore W2079384850C2780361556 @default.
- W2079384850 hasConceptScore W2079384850C2780427769 @default.
- W2079384850 hasConceptScore W2079384850C2780648877 @default.
- W2079384850 hasConceptScore W2079384850C2781212610 @default.
- W2079384850 hasConceptScore W2079384850C42219234 @default.
- W2079384850 hasConceptScore W2079384850C519063684 @default.
- W2079384850 hasConceptScore W2079384850C71924100 @default.
- W2079384850 hasConceptScore W2079384850C84393581 @default.
- W2079384850 hasConceptScore W2079384850C98274493 @default.
- W2079384850 hasLocation W20793848501 @default.
- W2079384850 hasLocation W20793848502 @default.
- W2079384850 hasOpenAccess W2079384850 @default.
- W2079384850 hasPrimaryLocation W20793848501 @default.
- W2079384850 hasRelatedWork W1735740492 @default.
- W2079384850 hasRelatedWork W1970935312 @default.
- W2079384850 hasRelatedWork W1992888257 @default.
- W2079384850 hasRelatedWork W2047466896 @default.
- W2079384850 hasRelatedWork W2050130494 @default.
- W2079384850 hasRelatedWork W2079384850 @default.
- W2079384850 hasRelatedWork W2102268427 @default.
- W2079384850 hasRelatedWork W2299416842 @default.
- W2079384850 hasRelatedWork W2403522199 @default.
- W2079384850 hasRelatedWork W48497034 @default.
- W2079384850 isParatext "false" @default.
- W2079384850 isRetracted "false" @default.
- W2079384850 magId "2079384850" @default.
- W2079384850 workType "article" @default.